WHO. Considerations for use of avian influenza A(H5) vaccines during the interpandemic and emergence periods: report of a WHO virtual scientific consultation, September 2024. WHO
WHO conducted a virtual scientific expert consultation on A(H5) vaccines and vaccination. This report provides an overview of the landscape of A(H5) vaccines and summarizes options for Member States´ potential use of A(H5) vaccination during the interpandemic and emergence periods.
See Also:
Latest articles in those days:
- Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses 6 hours ago
- Dynamic ensemble deep learning with multi-source data for robust influenza forecasting in Yangzhou 6 hours ago
- Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift 6 hours ago
- Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025 9 hours ago
- Avian influenza overview September - November 2025 1 days ago
[Go Top] [Close Window]
